Molecular Imaging (MI)

Our molecular imaging solutions are purposefully engineered to deliver highly detailed, sensitive images that uncover each patient’s unique biological signature. When integrated with advanced tracer technology and intelligent software designed to simplify workflows and accelerate clinical decision-making, they help make the path to personalized care faster, more transparent, and more efficient.

Nuclear Medicine

NM/CT 870 DR

The NM/CT 870 DR hybrid SPECT/CT system delivers high-performance imaging designed for advanced molecular and theranostic workflows. Featuring digital-ready detector architecture, high-sensitivity SPECT (with SwiftScan Planar/SPECT), and a built-in 16-slice CT for precise attenuation correction and metal artifact reduction, it offers exceptional quantitation and flexible upgrade potential. With SmartConsole workflow automation, dose and time-reduction technology, and seamless integration with PACS and mobile devices, it empowers departments to streamline hybrid imaging procedures, support quantitative analytics, and elevate patient-centric care.
Uncompromised image quality
Improved small lesion detectability with SwiftScan Planar and SwiftScan SPECT
Ready for Theranostics
Only scanner with easy, direct upgrade to CZT technology
Enhance producitivity
Simplify workflows for complex procedures with SmartConsole
AI solutions
Several quantitation-based applications, powered by AI on Xeleris™ V

NM/CT 860

The NM/CT 860 is a high-performance SPECT/CT platform engineered for demanding clinical environments. It integrates the advanced SPECT capabilities of the 800 Series—including elite NXT detectors, SwiftScan Planar/SPECT modes, and high-sensitivity LEHRS collimators—with an 8-slice CT (based on the Revolution ACTs) that provides thin-slice diagnostic capability, metal-artifact reduction, and low-dose imaging. The system’s modular, upgrade-ready SmartConsole workflow, large field-of-view gantry, and productivity-optimized design empower departments to extend service lines, streamline workflow, and optimize dose and time.
High-Sensitivity SPECT Imaging
Utilize the LEHRS collimator and SwiftScan technology to achieve up to 20% increased sensitivity, enabling reduced scan times or lower tracer doses while maintaining superior image quality for accurate diagnostics.
Automated SmartConsole Workflow
Streamline quantitative SPECT/CT studies with automated reconstruction and direct PACS integration, allowing technologists to review results at the console and physicians to assess scans remotely for enhanced productivity.
Advanced CT Integration
Leverage the Revolution™ ACTs eight-slice CT with IQ Enhance for fine-resolution imaging and faster helical scans, covering more anatomy with consistent quality for both SPECT/CT and standalone CT exams.
Modular and Future-Ready Design
Benefit from a shared user interface and collimators across the 800 Series, enabling easy upgrades and access to future enhancements like cloud analytics, ensuring long-term adaptability and cost efficiency.

PET/CT

Omni Legend

The Omni Legend introduces a groundbreaking all-digital PET/CT platform engineered to deliver exceptional sensitivity and resolution. With its next-generation Omni Digital Detector, the system offers some of the highest NEMA sensitivity per centimeter in the market, enabling fast scans at lower doses and improved small-lesion detectability. Advanced deep-learning image reconstruction with Precision DL, streamlined AI-driven workflow, and theranostics-ready capabilities make it well-suited for oncology, neuro, cardiac, and multi-tracer applications. Designed for today’s demands and tomorrow’s growth, Omni Legend delivers speed, clarity, and flexibility in a single PET/CT system.
See small lesions
Better than the top digital platform
Highest sensitivity
Highest sensitivity per cm 2 thanks to brand new digital detector
Ultra-fast scans
With optimized workflow and multidimensional clinical flexibility

Discovery MI Gen 2

The Discovery MI Gen 2 is an advanced digital PET/CT system engineered for maximum sensitivity and diagnostic confidence. With GE’s LightBurst™ digital detector and an axial field-of-view scalable up to 30 cm, it achieves system sensitivity up to 30 cps/kBq and a marked improvement in small-lesion detectability. Deep-learning reconstruction (TrueFidelity™) paired with high-performance diagnostic CT enhances image texture and quantification, while workflow tools like Q.Clear™ quantitation and MotionFree™ motion correction streamline exams and boost throughput. Ideal for oncology, neurology, cardiology, and whole-body dynamic imaging, Discovery MI Gen 2 helps clinicians capture more detail faster—supporting better patient outcomes with fewer compromises.
Unrivaled PET Sensitivity
Harness the LightBurst Digital Detector with a scalable 30 cm field of view to achieve industry-leading sensitivity of up to 30 cps/kBq, enhancing small lesion detection and reducing scan times or tracer doses.
AI-Enhanced CT Imaging
Leverage TrueFidelity™ deep-learning reconstruction for diagnostic CT, delivering textbook-quality image texture with low-dose efficiency, improving diagnostic confidence across diverse patient profiles.
Whole-Body Dynamic Imaging
Utilize the WB Dynamic IQ Protocol to capture detailed metabolic activity, distinguishing malignancies from benign tracer uptake, enabling precise diagnosis with fewer bed positions.
Efficient Technologist Workflow
Streamline operations with an intuitive interface, MotionFree technology for automatic respiratory correction, and Q.Clear for up to twice the quantitative accuracy, optimizing clinical productivity.

MotionFree

MotionFree is the first-ever digital respiratory motion-management solution for PET/CT that requires no external gating device. It continuously monitors respiratory motion throughout the scan, automatically adjusts acquisition parameters in real time, and integrates corrections into the final image to improve clarity and quantitation. With up to a ~67% improvement in lesion-volume measurement and up to ~30% better SUV quantitation accuracy, it helps reduce setup time, simplify workflow, and deliver greater confidence in diagnosis and therapy planning.
Device-Free Motion Correction
Automatically detect and correct respiratory motion in real time without external hardware, ensuring every patient benefits from clearer images and improved diagnostic reliability.
Enhanced Quantitative Accuracy
Achieve up to 30% improvement in SUVmean and volume measurements through advanced reconstruction, enabling precise staging and treatment planning for small lesions.
Streamlined Workflow Efficiency
Reduce setup time by up to 11 minutes compared to traditional gating devices, with flexible bed position selection for motion correction, boosting throughput and operational efficiency.
Patient-Centric Comfort
Eliminate the need for chest-mounted hardware or specific breathing instructions, allowing patients to relax naturally during scans, enhancing their experience and compliance.

Discovery IQ Gen 2

The Discovery IQ Gen 2 builds upon its predecessor with enhanced digital detector performance, superior motion-correction technology (MotionFree), and advanced quantitation tools. It delivers high system sensitivity and a scalable axial field of view for improved small-lesion detectability, while maintaining efficient workflow and lower radiation dose. Engineered for clinical settings that demand speed, precision, and adaptability, it supports oncology, cardiology, neurology, and hybrid applications with confidence.
High NEMA sensitivity
for exceptional small lesion detectability
High clinical NECR
for clinical 18F
Enhanced patient care
comfort and satisfaction
Motion correction & quantitation accuracy
Improvements to two core pillars of PET/CT imaging

PET Radiopharmacy

Cyclotrons

PETtrace 800 series

The PETtrace 800 Series cyclotron is designed for high-capacity, high-reliability PET isotope production. It integrates a fully automated workflow and compact footprint to streamline installation and operation. With versatile tracer production capability, minimal maintenance requirements, advanced personnel shielding, and a continuous upgrade path, PETtrace 800 Series supports both clinical-scale and regional distribution needs.
High-Capacity Tracer Production
Achieve multi-Curie production with 99.9% beam extraction efficiency, supporting simultaneous dual-target irradiation to deliver a diverse portfolio of PET tracers for clinical and research applications.
Automated Solid Target Platform
Streamline radiometal production with fully automated processes and FASTlab™ synthesizer integration, enabling single-operator efficiency and consistent, high-quality tracer output.
Integrated Radiation Shielding
Utilize strategically designed lead and boronated water shields to eliminate the need for large bunkers, reducing radiation exposure and simplifying site planning for enhanced safety and cost efficiency.
Versatile and Scalable Design
Benefit from a compact, upgradable system with proton and deuteron acceleration capabilities, allowing seamless expansion of tracer types and production capacity to meet growing demands.

MINItrace

The MINItrace cyclotron is a compact, fully automated solution built to expand tracer production in-house or at smaller sites. Despite its small footprint, it supports the production of tracers for multiple PET/CT scanners while delivering automated operation, simplified maintenance, and reduced staffing requirements. Ideal for growing molecular-imaging programs, it opens the door to neurology, cardiology, and beyond.
High-Yield Isotope Production
Achieve consistent production of key PET tracers like FDG and Gallium-68 with the capacity to support multiple daily runs, ensuring reliable supply for clinical and research applications.
Compact and Flexible Design
Benefit from one of the smallest clinical cyclotron footprints with optional self-shielding, simplifying installation in existing facilities and reducing infrastructure costs.
Automated Workflow Efficiency
Streamline operations with fully automated processes and intuitive interfaces, enabling single-operator control and minimizing setup time for enhanced productivity.
Versatile Tracer Capabilities
Configure the system with various target systems and chemistry modules to produce a wide range of tracers, supporting applications in oncology, neurology, and cardiology.

GENtrace

The GENtrace cyclotron is engineered for in-house PET isotope production with a compact, automated design that allows operation by trained technologists. Built on a vertical mid-plane architecture that reduces footprint and maintenance exposure, it supports efficient production of isotopes such as F-18 and C-11. It offers robust uptime and scalability to meet research and clinical demands.
Efficient Tracer Production
Produce key PET isotopes with high yield using a reliable 9 MeV proton cyclotron, supporting multiple daily runs for clinical diagnostics and research with minimal operator intervention.
Compact Self-Shielded Design
Benefit from a space-saving system with built-in shielding, eliminating the need for large bunkers and enabling easy installation in existing facilities for cost-effective setup.
Fully Automated Workflow
Streamline operations with intuitive automation and single-operator control, minimizing setup time and ensuring consistent, high-quality tracer output for enhanced productivity.
Versatile Isotope Capabilities
Support a broad range of radiotracers for oncology, cardiology, and neurology through flexible target systems, meeting diverse clinical and research needs with precision.

PET Radiochemistry Systems

TRACERcenter Solution